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ABSTRACT 
Background: Anthrax is a zoonotic disease that is caused by Bacillus Anthracis is transmitted to 
humans through infected animal. The transmission to humans occurs when there is a contact to 
animals or animal products contracting anthrax. Clinical skin manifestations and anthrax serum Ig 
G antibody can be used to diagnose infected anthrax animals. This study aimed to determine the 
prevalence of anthrax based on ELISA serum Ig G antibody and clinical skin manifestations 
occurring in patients with anthrax. 
Subjects and Method: This was a descriptive study with cross sectional design conducted in 
Sragen district, Central, Indonesia, in 2015. A sample of 101 patients infected with anthrax was 
examined based on clinical skin manifestations and anthrax serum Ig G antibody. 
Results: 39.6% of the sample was 21 to 40 years of age. 57.4% of the sample was female. 74% of 
the sample completed primary school. 21% worked as farmers. 30.5% of the sample who cooked 
and consumed meat showed positive Ig G. Test results showed serum Ig G antibody negative 50%, 
15.8% and 33.7% borderline positive. Clinical manifestations in the skin as much as 11.9%, which is 
the eschar on all respondents and 92.8% showed positive Ig  G. While 88.1% did not show any 
clinical signs of anthrax. 
Conclusion: The increase in serum antibody titer Ig G anthrax is not all respondents were 
exposed, in an area that otherwise outbreak of anthrax, which is only a third of all respondents, and 
when it comes up eschar will be followed by an increase in Ig G antibody titer. 
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BACKGROUND 
Anthrax is a zoonotic disease that can be 
transmitted to humans from animals af-
fected of anthrax. A bacillus anthracis bac-
terium often affects animals such as cows, 
sheep, goats, and camels. Transmission to 
human occurs when there is contact of 
animals suffered anthrax directly. It can be 
a skin, blood, and flesh. In addition, trans-
mission can also occur when a person in-
hales the spores of diseased animal pro-
duct, example skin or fur dried (Thunder, 
2011) 
The prevalence of anthrax in the 
world, in United States, there were 400 
cases of anthrax during 1845-1955. Eighty 
percent of patients contact with wool, goat 
hair, or their imported products from Asia, 
Africa, and the Middle Eastern. In 1945, the 
extraordinary events have occurred in one 
million sheep die, so that vaccination pro-
gram to be done in masse. It made morta-
lity in pets dropped. Anthrax spores re-
mains in the soil some parts of the world. It 
was also reported six cases of anthrax in 
1978 that struck the agriculture and textile 
factory employees than England in period 
1965 to 1980. That found 145 cases, which 
were 23 no related to work, 19 male and 15 
as workers fodder (Dixon 2005). 
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Currently the anthrax incident in In-
donesia occurred in eleven provinces spre-
ad across islands in the country, namely in 
Koala, South Sulawesi in 1832, there were 
36 patients died after eating meat in 1969. 
Four years later four patients died after 
eating meat infected of anthrax in Betung 
Gulf, Lampung in 1884, Buleleng, Bali and 
Palembang, East Sumatera in 1885. Bima, 
NTB in 1976 and Paniai, Irian Jaya in 1985 
thousands of dead pigs and 11 patients died 
from eating pork. A total of 48 cases hap-
pened in Semarang, Boyolali, and Demak 
(Central Java) in 1990 with no death. The 
last occurrence in 1992, when anthrax 
attack Kopen, Teras, Boyolali, Central Java 
on the incident recorded 25 patients tested 
positive for anthrax and 18 of them dead. 
The period of the last ten years has 
occurs five times the plague that in 1996 of 
Purwakarta, Subang, Bekasi, and Kara-
wang, in 1997 of Purwakarta, Subang and 
Karawang. In 1999 in Purwakarta, Subng 
and Bekasi  and in 2000 anthrax attack 
West Java with 32 cases in 2001 in Bogor 
with 22 patients infected with the death of 
two patients. This happened when Eid 
Adha of Coventry Cibinong and Babakan 
Madang which resulted in two patients 
died. 
On February 2011, in Boyolali obtain a 
single cow that died of anthrax. The case 
was attacked nine patients, without death. 
It because patients do not know when the 
cow slaughtered and consumed in the 
vicinity was sick cow. On May 2011 out-
break in Sragen, Central Java with patients 
as 13 cases with no death (Mardianto 2011). 
 
SUBJECTS AND METHOD 
This was an analytic observational study 
with cross sectional design. It performed 
immunoassay based on patients exposed to 
anthrax outbreak in 2011. The samples were 
extraordinary outbreak of anthrax areas in 
Boyolali and Sragen, Central Java. This in-
cident occurred in February and in No-
vember 2011 in Boyolali, and in May in Sra-
gen. All persons exposed to animals that 
died from anthrax, a blood sample for 
examination Ig G antibody serum by Exam-
ination of Enzyme-Linked Immunosorbent 
Assay (ELISA).  
ELISA aimed to determine the serum 
antibody titer Ig G anthrax exposed to an-
thrax analyzed using Calbiotech Anthrax 
Protective Antigen (PA) Ig G ELISA Kit in 
Biomedical Laboratory of Medical Faculty, 
Sebelas Maret University of Surakarta.  
Definitions  
Anthrax is a zoonotic disease that occurs in 
animals, especially herbivores that can be 
transmitted to humans, direct or indirectly 
(Thunder, 2011). 
Risk Factors 
The risk transmission will occur when there 
is direct with infected animals or the 
environment in his life (cage) or from the 
product of sick animals for example skin, 
hair that has been dried, it can even happen 
due to slaughtering, flaying, cooking then 
eating meat of animal infected with anth-
rax. (Redhono, 2011).  
Clinical manifestations 
Anthrax appears as cutaneous anthrax, res-
piratory (inhalation anthrax) and digestive 
(gastrointestinal anthrax). Ninety-five per-
cent of cases in the world are cutaneous 
anthrax, which is mostly the case with a 
better prognosis than other types of inhala-
tion and gastrointestinal. Cutaneous anth-
rax usually occurs due to their history of 
contact animal and their products, which is 
marked by the entry of bacteria or anthrax 
spores penetrate the skin through a lesion 
on the skin, such as when doing slaughter-
ing process (cutting, skinning, or divide 
meat) with anthrax infected. There was a 
low level of germination at the location 
where the entry of the spores and cause 
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lesions in the skin itchy, then raised 
papuler lesions and develop into vesicles 
accompanied by edema and pain. These 
lesions then become local necrosis with 
eschar formation and soft tissue edema. 
Germination occurs within 1-3 hours after 
inoculation, but this germination cannot 
cause infection of the skin intact. Endospo-
res will undergo phagocytosis by macropha-
ges and then be taken to the regional lymph 
nodes, causing lymphadenopathy and lym-
phangitis (Scott 2009). 
Location is often the case is on the 
face, extremities or the neck. Endospores 
enter through skin abrasions or cuts. One to 
seven days after entry endospores, formed a 
primary skin lesion that is not painful and 
itchy papules. Twenty-four to 36 hours later 
lesions forming vesicles containing clear 
liquid or serosanguineus containing many 
gram-positive bacteria. Vesicle then under-
goes central necrosis, dry out and cause 
eschar (necrotic ulcers) distinctive blackish 
purple with edema and vesicles. Edema 
usually occurs more severe on the body 
than the head or neck or leg. Lymphangitis 
and lymphadenopathy pain can be found 
following systemic symptoms occur. Al-
though anthrax skin can heal itself, but still 
need to be given antibiotics (to reduce sys-
temic symptoms occur). In 80-90% of cases 
the lesions recover completely without 
complications or scarring (Scott 2009). 
Gastrointestinal anthrax usually oc-
curs 2-5 days after eating raw or under-
cooked meat that is contaminated with 
germs. On pathological examination using 
microscope can be found bacilli in the 
mucosa and sub-mucosa and lymphadenitis 
mesenteric lymph tissue. Ulcerations al-
most always found. A large number of 
gram-positive bacteria can be found in the 
peritoneal fluid. Clinical symptoms can in-
clude fever, diffuse abdominal pain, consti-
pation or diarrhea. Ascites can occur with 
clear liquids until purulent (WHO 2010). 
Inhalation anthrax spores began with 
the entry into the alveolar cavity, then ma-
crophages will phagocytic spores and most 
of the spores will lysis and broken. Spores 
are still alive will spread to the lymph nodes 
and mediastina nodes. The process of 
change in vegetative form occurs approxi-
mately 60 days later. The slow process of 
change in shape is not known with cer-
tainty, but well documented in Sverdlovsk 
that inhalation anthrax cases occurred 
between day 2 to day 43 after exposure. 
Once germination has occurred, the disease 
will arise quickly and replication of the 
bacteria causing hemorrhage, edema and 
necrosis (Pile 2005). 
Examination Support Anthrax 
Diagnosis of anthrax can be confirmed with 
confirmation of the results of routine blood 
tests, culture swab on the wound or blood 
(on the skin), phlegm (on inhalation) chest 
X-ray (on inhalation), electrolyte (GI) and 
serology using ELISA (Enzyme Linked 
Immunosorbent Assay) and PCR (Polyme-
rasi Chain Reaction). Samples were taken 
for laboratory examination of the above is 
blood serum, rub the injured area, phlegm 
and land near the cage or a dead animal 
(Dirgahayu 2011). 
ELISA procedure begins with the 
collection of samples for the ELISA test, 
namely: 
1. The specimens used were obtained from 
blood serum suspected anthrax in the 
field. And serum is obtained by centri-
fugation. 
2. For the purposes of transport of samples 
from a remote location so that the sam-
ple must be outside lab> 2 hours, sam-
ples should be brought in a thermos of 
ice/ refrigerated at 2-8 ° C, it can last for 
as long as seven days or frozen if it needs 
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to be stored for an extended period time 
for six months. 
3. Avoid repeated freezing and thawing 
process of the sample. To avoid this, the 
sample should be made directly aliquots 
and stored frozen. 
Sampling and handling samples for the 
ELISA test, namely: 
1. The specimens were obtained from blood 
samples were then centrifuged to obtain 
the sample. 
2. Prior to the analysis, the specimen can 
be kept in a refrigerator at a temperature 
of 2-8˚ C for 6 months. Aliquot samples 
should be done to prevent damage to the 
protein. 
3. Preparation of reagents required ie 
Washing Buffer. Prepared by adding 
washing buffer (25 ml of 20x washing 
buffer is added to 475 ml of distilled 
water. Store at room temperature. 
All specimens and Reagent Kit is 
brought to the room with room tempera-
ture (18-26 ° C) and slowly do the mixing, 
by: (Dirgahayu 2011) 
1. Place sticker and make labeling of all 
samples correctly 
2. The negative control, positive control 
and calibrator prepared. 
3. Prepare a 1:41 dilution of the sample 
solution by adding 200 L diluting the 
sample into the sample 5 L. Mix gently. 
4. Enter 100 L serum that has been dilute-
ed, the solution calibrator and control 
solutions in wells ELISA plate. As a 
negative control used 100 L diluent 
buffer and put into wells at number 1A. 
Tap-tap the tray slowly to remove the air 
bubbles and mix gently with the 
micropipette with its tip replacing each 
sample change. Leave at room tempera-
ture for 30 minutes. 
5. Discard the liquid in the tray wells and 
wash wells 3 times with 300 L 1x wash-
ing buffer. Attach the surface of the tray 
to the paper towel so that the liquid can 
come out entirely. 
6. Enter 100 L TMB substrate solution in 
wells ELISA tray. Let stand for 10 
minutes at room temperature. 
7. Add 100 L buffer stop solution to stop 
the reaction of the TMB working solute-
ion. 
8. Later in the ELISA tray insert into the 
machine ELISA (micro well reader)to 
read the OD value of absorbance at 450 
nm 
Interpretation of ELISA test results are: 
<0.9: Negative, is not detected IgG anti-
bodies against the protein PA on ELISA. 
0.9-1.1: Borderline positive. Recommended 
for reexamination. 
> 1.1: Positive, is detected IgG anti-bodies 
against proteins PA, pa-tients indicated be-




The basic characteristics of research sub-
jects. 
Table 1. Basic characteristics of re-
search subjects  
Variables n % 
Gender   
Male 43 42.6 
Female 58 57.4 
Age   
0-20 years 2 1.9 
21-40 years 40 39.6 
41-60 years 37 36.6 
61-80 years 22 21.7 
Educations   
Elementary School 75 74.3 
Junior High School 15 14.9 
Senior High School 5 5.0 
Bachelor 6 6.0 
Occupations   
Doesn’t work 48 47.6 
Peasants 22 21.8 
Civil Servants 5 5.0 
Entrepreneur 26 38.8 
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In this study, 101 patients with a his-
tory of contact with animals infected with 
anthrax. The youngest age is 6 years (1%) 
and the oldest 80 years (1%). The dis-
tribution of age is the highest in the 21 to 
40 years as much as 39.6%, and most were 
female gender, i.e. 57.4%. The education 
level of most respondents is 74.3% finished 
primary school, farmers as much as 21.8%. 
The results obtained Ig G serum 
antibody showed a negative 50.5%, 15.8% 
and 33.7% borderline positive. ELISA sero-
logy results are shown in Table 2. 
 
Table 2. ELISA Inspection Results 
Variabels n % 
Positive 34 33.7 
Borderline 16 15.8 
Negative 51 50.5 
 
In cross-table analysis results between 
the risk factors contact with ELISA serology 
results obtained respondents who cook and 
eat at the same time is the highest risk on 
the results of serological positive 20.8%. 
Serology results Elisa Risks associated with 
the contact listed in Table 3. 
 
Table 3. Results Serology Elisa Risks 










1 0 1 
Eat 10 5 16 
Wash 
and Eat 
3 2 0 
Cook 
and Eat 




9 3 13 
Be close 
to cage 
0 0 0 
 
Overall there are 11.9% of respondents 
who showed clinical signs of the emergence 
in the skin in the form of vesicles, accompa-
nied by fever and ulcers that ended with the 
formation of eschar. The skin manifestat-
ions can be seen in Table 4. 
 
Table 4. Skin Manifestations in The 
Form of Eschar 
Skin Manifestations n % 
Eschar 12 11.9 
No eschar 89 88.1 
 
At respondents with positive serology 
results showed 10.9% of skin manifestation 
of the emergence of eschar, while only 1.0% 
with borderline serology that shows cutane-
ous manifestations.  
Twenty two percent of respondents 
with positive ELISA results, but does not 
cause any manifestation in the skin of 
eschar or other clinical signs (fever, myal-
gia, cough, tightness, nausea and vomiting). 
Elisa serology associated with skin manifes-
tations in the form of eschar can be seen in 
Table 5. 
 
Table 5. Results Serology Elisa Associa-
ted with Cutaneous Manifestations in 





Exist 11 (10.9%) 1 (1%) 0 (0%) 
Doesn’t 
ExisT 




Contact risk factors to the emergence 
of skin manifestations, especially on the 
respondents were slaughtered at once ate 
beef (6.0%), followed by washing and 
eating meat, at 3.0%, while only wash the 
meat by 1.0%, Contact by simply eating 
meat only, obtained 2% which will appear 
the eschar. The relationship between con-
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tacts with the manifestation of the emer-
gence of eschar can be seen in Table 6. 
 
Table 6. Relationship between contacts 
with the manifestation of the emer-







1 (1%) 1 (1%) 
Eating 2 (2%) 29 (28.7%) 
Washing and 
Eating 
3 (3%) 2 (2%) 
Cooking and 
Eating 
0 (0%) 36 (35.6%) 
Slaughtering 
and Eating 
6 (6%) 19 (18.9%) 
Be Close to 
The Cage 
0 (0%) 2 (2%) 
 
DISCUSSION 
In January 2011 obtained a cow belonging 
to one of the people who suddenly fall and 
accompanied by seizures. The owners de-
cided to slaughter cattle meat and sold to 
citizens as much as 40 packs. Samples of 
meat and cow's blood is checked in Lab-
kesda Central Java Province and tested 
positive for anthrax. Seven days later seven 
residents who complained there was little 
bumps and itching, accompanied by swell-
ling and wet lesions in the area under the 
eyes, hands, legs or feet, then taken to a 
health center and declared suspected anth-
rax. Furthermore, the derah declared out-
breaks of anthrax. Then in May 2011 in 
Sragen also occurred the same thing and 
some people who show symptoms of ant-
hrax skin contact. 
Clinical manifestations such as eschar 
present in 11.9% of the respondents and all 
bermanifetasi as Antrak skin (cutaneous 
anthrax). Respondents were drawn from 
these two locations, got 101 serological 
samples are then examined serum Ig G 
Antibody anthrax. Of these 50.5% negative 
and 33.7% positive, while 15.8% borderline. 
Clinical manifesttations in the form of a 
skin disorder that begins their benjoalan or 
injury which later lead to edema and end 
with eschar present in 10.9% of the res-
pondents were Ig G antibody positive and 
1.0% of respondents with Ig G borderline 
results. This is due to the emergence of 
antibodies against the anthrax bacteria on 
respondents who had clinical manifestat-
ions in the skin, but that cannot be explain-
ed is the result of antibodies obtained also 


















Picture 1. Anthrax manifestations in the 
skin with eschar appearance. 
Twenty-two percent of respondents 
with positive serum Ig G antibody did not 
give rise to clinical manifestations. This 
might be due to the immune responder, 
bacterial virulence factors and the amount 
of exposure that occurs may not be too 
much. However this cannot be explained 
further, because of the durability factor of 
the bodies of all the conditions are similar, 
which is probably due to the virulence of 
germs and bacteria that enter the number. 
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The risk of direct contact, namely cook-
ing and eating the flesh of infected animals 
showed 30.5% IgG positive results, but did 
not cause clinical manifestations with the 
advent of eschar (0%). This may be due to 
immune factors from the patient and the 
virulence of B antrhacis that enter the body. 
Risk factors for eating just 32% of respon-
dents showed positive results. While the 
risk factors slaughter and eat 24% of the 
skin manifests with the appearance of the 
eschar. The increase in serum antibody titer 
Ig G anthrax is not all respondents were ex-
posed, in an area that otherwise outbreak of 
anthrax, which is only a third of all res-
pondents, and when it comes up eschar will 
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